RH&PARTNER Investment Funds SICAV-RH&P Global Life Sciences Fund I Cap CHF/ LU1120849671 /
| NAV01/10/2024 | Diferencia-0.1900 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 91.0100CHF | -0.21% | reinvestment | Equity Worldwide | FundPartner Sol.(EU) ▶ |
Rendimiento mensual
| ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 4.24 | -4.03 | -5.75 | 2.46 | -1.14 | 5.64 | -2.48 | 3.04 | -4.81 | -0.72 | -5.75 | 2.19 | -7.71% |
| 2022 | -8.93 | -2.22 | 3.21 | -8.15 | -0.80 | 0.65 | 2.61 | -2.58 | -4.48 | 8.48 | 6.52 | -1.81 | -8.70% |
| 2023 | 3.80 | -6.78 | 0.09 | -2.33 | -0.44 | -1.29 | 2.44 | -1.60 | -5.53 | -8.57 | 5.39 | 9.29 | -6.76% |
| 2024 | -3.19 | 0.91 | 2.13 | -5.36 | 2.68 | 4.58 | 4.75 | 2.70 | -2.64 | -0.21 | - | - | - |
Valores estimados
| Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
|---|---|---|---|---|---|
| Volatilidad | 13.92% | 13.99% | 15.49% | 20.06% | -% |
| Índice de Sharpe | 0.35 | 0.75 | 0.60 | -0.39 | - |
| El mes mejor | +9.29% | +4.75% | +9.29% | +9.29% | - |
| El mes peor | -5.36% | -5.36% | -8.57% | -8.93% | - |
| Pérdida máxima | -9.88% | -7.68% | -9.88% | -30.41% | - |
| Rendimiento superior | - | - | - | - | - |
Todas las cotizaciones en CHF
Tramos
| Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
|---|---|---|---|---|---|
| RH&P Glob. Life Sciences Fd. I c... | paying dividend | 97.6400 | +15.26% | -9.41% | |
| RH&PARTNER Investment Funds SICA... | reinvestment | 91.0100 | +12.51% | -13.08% | |
| RH&PARTNER Investment Funds SICA... | reinvestment | 182.3900 | +16.73% | -5.06% |
Performance
| Año hasta la fecha | +5.99% | ||
|---|---|---|---|
| 6 Meses | +6.68% | ||
| Promedio móvil | +12.51% | ||
| 3 Años | -13.08% | ||
| 5 Años | - | ||
| 10 Años | - | ||
| Desde el principio | -16.73% | ||
| Año | |||
| 2023 | -6.76% | ||
| 2022 | -8.70% | ||
| 2021 | -7.71% | ||
